TG and osteosarcoma: In the vast majority of research studies over the past two decades, only combination of major (natural immunity), minor (thyroid hormone status), and additional (bone tumor angiogenesis) markers has been applied as a "gold standard" for monitoring and diagnosis of pediatric osteosarcoma patients.